Molecular mechanisms of action of bisphosphonates
- 22 April 1999
- Vol. 24 (5) , 73S-79S
- https://doi.org/10.1016/s8756-3282(99)00070-8
Abstract
No abstract availableThis publication has 59 references indexed in Scilit:
- Identification of adenine nucleotide-containing metabolites of bisphosphonate drugs using ion-pair liquid chromatography–electrospray mass spectrometryJournal of Chromatography B: Biomedical Sciences and Applications, 1997
- The Management of Paget's Disease of BoneNew England Journal of Medicine, 1997
- The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H+-ATPaseJournal of Bone and Mineral Research, 1996
- Human protein tyrosine phosphatase-σ: Alternative splicing and inhibition by bisphosphonatesJournal of Bone and Mineral Research, 1996
- Alendronate distributed on bone surfaces inhibits osteoclastic bone resorption in vitro and in experimental hypercalcemia modelsBone, 1995
- BisphosphonatesDrugs, 1991
- Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro.Journal of Clinical Investigation, 1990
- Dichloromethylenebisphosphonate (Cl2MBP) inhibits bone resorption through injury to osteoclasts that resorb Cl2MBP-coated boneBone and Mineral, 1989
- The acute-phase response after bisphosphonate administrationCalcified Tissue International, 1987
- The effect of several diphosphonates on acid phosphohydrolases and other lysosomal enzymesBiochimica et Biophysica Acta (BBA) - Enzymology, 1976